Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -5.682M
March 31, 2026 -7.089M
December 31, 2025 -1.671M
September 30, 2025 -8.889M
June 30, 2025 -7.753M
March 31, 2025 -11.60M
December 31, 2024 -3.358M
September 30, 2024 0.311M
June 30, 2024 -9.786M
March 31, 2024 -9.903M
December 31, 2023 -6.748M
September 30, 2023 -10.13M
June 30, 2023 -13.59M
Date Value
March 31, 2023 -17.51M
December 31, 2022 -15.63M
September 30, 2022 -20.46M
June 30, 2022 -18.65M
March 31, 2022 -22.19M
December 31, 2021 -10.88M
September 30, 2021 -16.80M
June 30, 2021 -12.70M
March 31, 2021 -12.97M
December 31, 2020 -8.852M
September 30, 2020 -8.734M
June 30, 2020 -5.467M
March 31, 2020 -10.07M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Integra LifeSciences Holdings Corp. 10.50M
Abbott Laboratories 1.991B
AngioDynamics, Inc. -18.48M
Alphatec Holdings, Inc. -1.582M
AtriCure, Inc. 18.43M